Thursday, 5 November 2026
M
Meridian Globe
Live briefing
Indonesia chief of staff sacked for allegedly wiretapping President Prabowo— 日经 Nikkei AsiaTencent says its Hy4 joins 'top-tier' of open-source AI models— 日经 Nikkei AsiaSony raises annual profit forecast on Spider-Man hit, gaming gains— 日经 Nikkei AsiaIndonesia's GDP grows 5.5% in Q3, helped by government spending— 日经 Nikkei AsiaToyota ready to 'regain market share' in China on expanded local sourcing— 日经 Nikkei AsiaTaiwan's chipmakers shine brightest in living memory— 日经 Nikkei AsiaAsian stock markets drop as Democratic win stokes fears over AI scrutiny— 日经 Nikkei AsiaHong Kong activist Joshua Wong sentenced to 10 years for foreign collusion— 日经 Nikkei AsiaIndonesia chief of staff sacked for allegedly wiretapping President Prabowo— 日经 Nikkei AsiaTencent says its Hy4 joins 'top-tier' of open-source AI models— 日经 Nikkei AsiaSony raises annual profit forecast on Spider-Man hit, gaming gains— 日经 Nikkei AsiaIndonesia's GDP grows 5.5% in Q3, helped by government spending— 日经 Nikkei AsiaToyota ready to 'regain market share' in China on expanded local sourcing— 日经 Nikkei AsiaTaiwan's chipmakers shine brightest in living memory— 日经 Nikkei AsiaAsian stock markets drop as Democratic win stokes fears over AI scrutiny— 日经 Nikkei AsiaHong Kong activist Joshua Wong sentenced to 10 years for foreign collusion— 日经 Nikkei Asia

Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia

Source Nature 生命科学2d ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Science
Region
Global
Language
English
Item ID
science-5e9eca3a

Comments 0 comments

No comments yet. Be the first.

Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia · Meridian Globe